ABBOTT LABORATORIES Cash & Short-Term Investments 2006-2026 | ABT
Beta
What is ABBOTT LABORATORIES's current cash & short-term investments?
ABBOTT LABORATORIES (ABT) annual cash & short-term investments for 2025 was $8.94B, a 12.20% increase from 2024. ABBOTT LABORATORIES cash & short-term investments for the quarter ending March 31, 2026 was $7.29B.
What was ABBOTT LABORATORIES's cash & short-term investments in 2024?
ABBOTT LABORATORIES annual cash & short-term investments for 2024 was $7.97B, a 9.45% increase from 2023.
What was ABBOTT LABORATORIES's cash & short-term investments in 2023?
ABBOTT LABORATORIES annual cash & short-term investments for 2023 was $7.28B, a 28.43% decline from 2022.
What is ABBOTT LABORATORIES's 5-year cash & short-term investments CAGR?
ABBOTT LABORATORIES cash & short-term investments grew at a compound annual growth rate (CAGR) of 4.57% from FY2020 to FY2025, going from $7.15B to $8.94B over 5 years.
Cash & Short-Term Investments History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+4.6%
FY2020
$7.15B
→
FY2025
$8.94B
0607080910111213141516171819202122232425
5 years selected
Cash & Short-Term Investments History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $8.94B | +12.2% | 10-K |
| FY2024 | $7.97B | +9.5% | 10-K |
| FY2023 | $7.28B | -28.4% | 10-K |
| FY2022 | $10.17B | -0.8% | 10-K |
| FY2021 | $10.25B | +43.4% | 10-K |
| FY2020 | $7.15B | +72.7% | 10-K |
| FY2019 | $4.14B | +1.3% | 10-K |
| FY2018 | $4.09B | -57.5% | 10-K |
| FY2017 | $9.61B | -48.8% | 10-K |
| FY2016 | $18.77B | +206.5% | 10-K |
| FY2015 | $6.13B | +37.3% | 10-K |
| FY2014 | $4.46B | -44.9% | 10-K |
| FY2013 | $8.10B | -46.6% | 10-K |
| FY2012 | $15.17B | +87.4% | 10-K |
| FY2011 | $8.10B | +48.5% | 10-K |
| FY2010 | $5.45B | -45.1% | 10-K |
| FY2009 | $9.93B | +95.5% | 10-K |
| FY2008 | $5.08B | +80.1% | 10-K |
| FY2007 | $2.82B | +441.2% | 10-K |
| FY2006 | $521.2M | - | 10-K |
Company: ABBOTT LABORATORIESTicker: ABTSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →